휴메딕스

200670KOSDAQ의약품 제조업

70.5 / 100

Reference Date: 2026-06-10

Financial Score33.5 / 40

News Sentiment20.0 / 25

Momentum2.0 / 20

Disclosure15.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Plunged 23.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HumeDx operates in two main business segments: the Aesthetic Division, producing fillers, botulinum toxin, cosmetics, and medical devices, and the CMO Division, specializing in specialty pharmaceuticals, osteoarthritis treatments, and raw material production. The company leverages its proprietary HI (High molecular Ideal reticulated matrix) technology to develop long-lasting fillers and high-performance cosmetics using pharmaceutical-grade HA and PDRN.

Number of Employees

377people

Average Salary

56.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

5.68Industry Average 11.938.0Point

Half of industry avg (excellent)

PBR

0.98Industry Average 0.892.5Point

Higher than industry avg (caution)

ROE

19.61Industry Average 4.017.0Point

4.9x industry avg (excellent)

Debt Ratio

1.15Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.7% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲6.9% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 17.6% (improving, 3yr)

Detailed News Sentiment

10 totalPositive 10Neutral 0Negative 0Average Sentiment Score 80

Positive
휴메딕스, 50억 규모 자기주식취득 신탁계약 체결 결정
휴메딕스가 주주가치 증대를 위해 자기주식 취득 신탁계약을 체결함으로써 긍정적인 주주 신뢰도 향상이 예상된다.
Positive
휴메딕스, 50억원 자사주 매입 결정…"주주가치 제고"
휴메딕스의 50억원 규모 자사주 매입 결정으로 주주가치 제고 기대.
Positive
기관투자가 떠난 자리 메운 '슈퍼개미'…형인우, 엔솔바이오에 또 50억...
슈퍼개미의 투자로 엔솔바이오의 자금 조달이 강화되어 신약 개발에 긍정적 영향을 미칠 것으로 예상됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 26,200Won52-week high 75,80052-week low 25,400

1-month return0.0Point

1m -23.05% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 3Neutral 3Negative 0

Neutral기업설명회(IR)개최2026-06-09
Positive주요사항보고서(자기주식취득신탁계약체결결정)2026-06-09
Neutral기업설명회(IR)개최2026-06-02
Neutral분기보고서 (2026.03)2026-05-15
Positive현금ㆍ현물배당결정2026-05-12